| Compounds and compositions as TLR activity modulators TYH Wu, Y Li, A Cortez, K Yue, X Zhang, M Singh, D Skibinski US Patent 9,045,470, 2015 | 70 | 2015 |
| Selective DYRK1A inhibitor for the treatment of Type 1 Diabetes: Discovery of 6-azaindole derivative GNF2133 YA Liu, Q Jin, Y Zou, Q Ding, S Yan, Z Wang, X Hao, B Nguyen, X Zhang, ... Journal of medicinal chemistry 63 (6), 2958-2973, 2020 | 64 | 2020 |
| Incorporation of phosphonate into benzonaphthyridine toll-like receptor 7 agonists for adsorption to aluminum hydroxide A Cortez, Y Li, AT Miller, X Zhang, K Yue, J Maginnis, J Hampton, DS Hall, ... Journal of medicinal chemistry 59 (12), 5868-5878, 2016 | 46 | 2016 |
| Compounds and compositions as toll-like receptor 7 agonists A Cortez, T Hoffman, Y Li, TYH Wu, X Zhang US Patent 9,944,649, 2018 | 27 | 2018 |
| Formulation of immunopotentiators M Singh, DAG Skibinski, TYH Wu, Y Li, A Cortez, X Zhang, Y Zou, ... US Patent App. 13/223,793, 2012 | 22 | 2012 |
| Compounds and compositions as TLR activity modulators TYH Wu, Y Li, A Cortez, Y Zou, P Mishra, X Zhang, D Skibinski, M Singh, ... US Patent 8,466,167, 2013 | 19 | 2013 |
| A Dual Inhibitor of DYRK1A and GSK3β for β‐Cell Proliferation: Aminopyrazine Derivative GNF4877 YA Liu, Q Jin, Q Ding, X Hao, T Mo, S Yan, Y Zou, Z Huang, X Zhang, ... ChemMedChem 15 (16), 1562-1570, 2020 | 12 | 2020 |
| Adsorption of immunopotentiators to insoluble metal salts M Singh, DAG Skibinski, TYH Wu, Y Li, A Cortez, X Zhang, Y Zou, ... US Patent 9,315,530, 2016 | 11 | 2016 |
| Compounds and compositions as TLR activity modulators TYH Wu, Y Li, A Cortez, Y Zou, P Mishra, X Zhang, N Valiante US Patent 8,895,577, 2014 | 5 | 2014 |
| Compounds and compositions as toll-like receptor 7 agonists Y Li, T Mo, VA Porino, TYH Wu, X Zhang | | 2021 |
| Compounds and compositions as toll-like receptor 7 agonists A Cortez, T Hoffman, Y Li, TYH Wu, X Zhang US Patent 10,844,068, 2020 | | 2020 |
| Compounds and compositions as toll-like receptor 7 agonists A Cortez, T Hoffman, Y Li, TYH Wu, X Zhang US Patent 10,407,431, 2019 | | 2019 |
| Adsorption of immunopotentiators to insoluble metal salts M Singh, DAG Skibinksi, TYH Wu, Y Li, A Cortez, X Zhang, Y Zou, ... US Patent 10,098,949, 2018 | | 2018 |
| Compuestos y composiciones como agonistas del receptor tipo toll 7 Y Li, JMM Garcia, P Va, TYH Wu, X Zhang | | 2018 |
| Compuestos y composiciones como moduladores de la actividad de TLR A Cortez, Y Li, M Singh, D Skibinski, TYH Wu, K Yue, X Zhang | | 2017 |
| Junginiai ir kompozicijos, kaip tlr aktyvumo moduliatoriai A Cortez, Y Li, M Singh, D Skibinski, TYH Wu, K Yue, X Zhang | | 2017 |
| Compounds and compositions as modulators of TLR activity A Cortez, Y Li, TYH Wu, K Yue, X Zhang, M Singh, D Skibinski | | 2017 |
| Compuestos y composiciones como agonistas del receptor tipo toll 7 T Mo, P Va, TYH Wu, Y Li, X Zhang | | 2017 |
| Compounds and compositions as toll-like receptor 7 agonists A Cortez, T Hoffman, Y Li, TYH Wu, X Zhang | | 2015 |
| Derivados de benzo [f]-1, 7-naftiridin-5-amina como moduladores de la actividad de tlr A Cortez, Y Li, TYH Wu, K Yue, X Zhang, M Singh, D Skibinski | | 2012 |
